Abveris Again Named as One of the Best Places to Work in 2022
Abveris Named as One of the Best Places to Work
Canton, MA—March 10, 2022—The Business...
Speaker
Tracey Mullen, VP/GM
Mice are one of the most common repertoire sources for in vivo antibody discovery. The choice of mouse model, immunization method, and/or screening strategy can significantly impact the drug discovery and development timeline. In this webinar, the scientific leadership of Abveris will discuss the following topics:
1. Challenges in the discovery of therapeutic antibodies against cell surface receptors and transmembrane proteins such as GPCR and ion channels
2. Overview of key selected technologies to access development-ready therapeutic leads, including the use of humanized mice and humanization of murine antibodies
3. A case study of an antibody discovery campaign against a cell surface receptor target using both humanized mice and proprietary hyperimmune (DiversimAb) mice for a risk-mitigated workflow under a rapid timeline
Here are more on-demand webinars that our team has put together for you
Overview of screening technologies for anti-Id antibodies discovery.
Dos and don'ts when planning and designing anti-Id discovery campaigns
Case studies of hybridoma-based and Beacon-based anti-Id campaigns targeting therapeutic biologics
Abveris Named as One of the Best Places to Work
Canton, MA—March 10, 2022—The Business...